跳至主要内容
临床试验/EUCTR2013-003125-28-NL
EUCTR2013-003125-28-NL进行中(未招募)1 期

Antiplatelet therapy for patients undergoing transcatheter aortic valve implantation - POPular-TAVI

St. Antonius Hospital0 个研究点目标入组 2,200 人开始时间: 2013年11月7日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
2,200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Heart team agrees on indication and treatment proposal;
  • 2.Patient has provided written informed consent;
  • 1.Heart team agrees on indication and treatment proposal;
  • 2.Need for long-term oral anticoagulation;
  • 3.Patient has provided written informed consent.
  • 1.Heart team agrees on indication and treatment proposal;
  • 2.Patient has provided written informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 2200

排除标准

  • 1.Need for long-term oral anticoagulation;
  • 2.Drug-eluting stent implantation within 3 months prior to TAVI procedure;
  • 3.Bare-metal stent implantation within 1 month prior to TAVI procedure;
  • 4.Allergy or intolerance to aspirin or clopidogrel.
  • 1.Drug-eluting stent implantation within 3 months prior to TAVI procedure;
  • 2.Bare-metal stent implantation within 1 month prior to TAVI procedure;
  • 3.Allergy or intolerance to clopidogrel.
  • 1.Patient is younger than 65 years old;
  • 2.Combination surgical procedure.

研究者

相似试验